Showing results (21-30 of 152) with videos related to
Sort By:
Pageof 16
Immunotherapy Advances|November 29, 2023
Impact of Fc receptors and host characteristics on myeloid phagocytic response to rituximab-treated 3D-cultured B-cell lymphomaSandra KleinauImmunotherapy Advances|October 16, 2023
Correction to: Immunology of allergen immunotherapyImmunotherapy Advances|March 9, 2026
PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposureMaria Lindén, Hifaa Al Remawi, Anna Fager, et al.Immunotherapy Advances|March 23, 2026
Neuraminidase A controls pneumococcal recognition and fate: deficiency enhances immune sensing and intracellular survival, while treatment promotes phagocytic clearanceKristine Farmen, Georgia Yfanti, Fabienne Geers, et al.Immunotherapy Advances|July 25, 2026
Growth factor supportive care for chemotherapy-induced neutropenia suppresses antitumour immunity in checkpoint blockade-responsive pancreatic cancerBrendan D Parent, Anthony E Kelly, Megan T Hoffman, et al.Immunotherapy Advances|April 6, 2026
Pharmacokinetics of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in pediatric patients with primary immunodeficiency diseaseZhaoyang Li, Yang Teng, Sharon Russo-Schwarzbaum, et al.Immunotherapy Advances|August 27, 2026
IVIG-associated anterior uveitis resolving after switch to subcutaneous immunoglobulinVered Schichter Konfino, Oded ShamrizImmunotherapy Advances|September 4, 2026
Safety and efficacy of PRaG therapy in elderly cancer patientsXiangrong Zhao, MengMeng Yang, Junjun Zhang, et al.Immunotherapy Advances|September 23, 2026
ImmTACs overcome cytotoxic T cell suppressionLan Huynh, Abdullah Aljohani, Amal Alsubaiti, et al.Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.Pageof 16